Candriam SCA’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Buy |
442,773
+3,674
| +0.8% | +$104K | 0.07% | 213 |
|
|
2025
Q1 | $13M | Buy |
439,099
+78,389
| +22% | +$2.31M | 0.08% | 213 |
|
|
2024
Q4 | $10.5M | Buy |
360,710
+37,314
| +12% | +$1.09M | 0.06% | 252 |
|
|
2024
Q3 | $14.9M | Buy |
+323,396
| New | +$14.9M | 0.09% | 217 |
|
|
2024
Q1 | – | Sell |
-290,067
| Closed | -$2.63M | – | 725 |
|
|
2023
Q4 | $2.63M | Buy |
290,067
+120,000
| +71% | +$1.09M | 0.02% | 448 |
|
|
2023
Q3 | $1.09M | Hold |
170,067
| – | – | 0.01% | 541 |
|
|
2023
Q2 | $1.89M | Hold |
170,067
| – | – | 0.01% | 510 |
|
|
2023
Q1 | $2.4M | Sell |
170,067
-41,000
| -19% | -$579K | 0.02% | 533 |
|
|
2022
Q4 | $4.68M | Hold |
211,067
| – | – | 0.03% | 391 |
|
|
2022
Q3 | $3.45M | Hold |
211,067
| – | – | 0.02% | 462 |
|
|
2022
Q2 | $3.07M | Buy |
211,067
+51,079
| +32% | +$742K | 0.03% | 408 |
|
|
2022
Q1 | $2.96M | Hold |
159,988
| – | – | 0.02% | 462 |
|
|
2021
Q4 | $3.8M | Buy |
159,988
+1,400
| +0.9% | +$33.3K | 0.02% | 410 |
|
|
2021
Q3 | $3.91M | Sell |
158,588
-1,400
| -0.9% | -$34.5K | 0.03% | 443 |
|
|
2021
Q2 | $3.95M | Buy |
159,988
+140,491
| +721% | +$3.47M | 0.03% | 450 |
|
|
2021
Q1 | $478K | Hold |
19,497
| – | – | ﹤0.01% | 710 |
|
|
2020
Q4 | $498K | Sell |
19,497
-503
| -3% | -$12.8K | ﹤0.01% | 723 |
|
|
2020
Q3 | $563K | Hold |
20,000
| – | – | 0.01% | 697 |
|
|
2020
Q2 | $565K | Buy |
+20,000
| New | +$565K | 0.01% | 691 |
|